Last reviewed: 5 Jan 2023
Last updated: 26 Oct 2022
26 Oct 2022

US Preventive Services Task Force recommends screening children 8 and older for anxiety

For the first time, the US Preventive Services Task Force (USPSTF) has recommended universal screening for anxiety in children ages 8-18 in pediatric primary care settings:

  • This applies to children without symptoms of anxiety, as well as those without a diagnosis of a mental health condition

  • Specific recommendations on screening tests are absent from the evidence report; primary care settings are encouraged to develop their own protocols after considering the types of anxiety disorders their clinicians might typically encounter, and also taking into account feasibility of available screening tools

  • The USPSTF could find no evidence on optimal screening intervals; they suggest that repeated screening may be most productive in adolescents with risk factors for anxiety

  • Opportunistic screening may be a practical approach for adolescents, who often present infrequently to primary care

  • For now, the USPSTF found that the evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger.

The USPSTF is an independent panel of US experts in disease prevention and evidence-based medicine. Their recommendations are based on a review of the evidence on screening for anxiety, which concluded with moderate certainty that it has a moderate net benefit in children ages 8-18. The report states that in 2018-2019, an estimated 7.8% of US children and adolescents had a current anxiety disorder. An important rationale for early detection and treatment of anxiety disorders in children and adolescents is that they are associated with an increased risk of anxiety and depression in later life.

See Diagnosis: screening

Original source of update



History and exam

Key diagnostic factors

  • anticipatory anxiety
  • behavioral avoidance
More key diagnostic factors

Other diagnostic factors

  • onset during childhood
  • onset during early adulthood
  • nausea
  • dizziness
  • disgust
  • fainting
  • tachycardia
  • hyperventilation
  • exaggerated startle
  • sleep disruption
Other diagnostic factors

Risk factors

  • somatization disorder
  • anxiety disorders
  • mood disorders
  • first-degree relative with phobia
  • twin with phobia
  • aversive experiences
  • stress and negative life events
  • female sex
  • white ethnicity
  • parental anxiety and overprotectiveness
  • negative affectivity and behavioral inhibition
  • cognitive/attentional bias
More risk factors

Diagnostic investigations

1st investigations to order

  • self-report
  • behavioral observation and approach tests
More 1st investigations to order

Investigations to consider

  • structured/semi-structured clinical interview
More investigations to consider

Treatment algorithm


adults with subclinical symptoms and infrequent interference with usual activities

adults with frequent symptoms interfering with usual activities

children with ongoing symptoms interfering with usual activities



Amy Huberman, MD

Instructor of Psychiatry

Johns Hopkins University School of Medicine




AH declares that she has no competing interests.


Dr Amy Huberman would like to gratefully acknowledge Dr Eve Friedl, Dr E. Blake Zakarin, Dr Craig N. Sawchuk, and Dr Bunmi O. Olatunji, previous contributors to this topic.


EKF and EBZ declare that they have no competing interests. CNS is an author of a reference cited in this topic. BOO is an author of a reference cited in this topic.

Peer reviewers

Jeffrey M. Lohr, PhD


Clinical Training Program

Department of Psychology

University of Arkansas




JML declares that he has no competing interests.

David F. Tolin, PhD

Associate Professor

Institute of Living

Yale University

New Haven



DFT declares that he has no competing interests.

  • Differentials

    • Agoraphobia
    • Panic disorder
    • Social anxiety disorder (social phobia)
    More Differentials
  • Guidelines

    • Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders
    • Exposure-based interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research
    More Guidelines
  • Patient leaflets


    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer